微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 9.58% | -5.89% | 62.1% | 28/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 5.91% | -24.62% | 118.89% | 28/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.7% | -24.79% | -80.21% | 42/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 13.64% | 0.52% | 33.99% | 14/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 10.18% | 0.3% | 29.85% | 23/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 7.84% | 21.17% | 118.38% | 14/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.59% | 24.22% | -73.54% | 23/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 13.57% | -19.66% | 33.69% | 24/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 10.15% | -22.04% | 56.88% | 30/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 6.47% | -26.14% | 123.88% | 32/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.89% | -43.44% | -82.89% | 41/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 16.89% | -8.41% | 29.72% | 17/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 13.02% | -0.31% | 48.63% | 15/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 8.76% | 18.38% | 71.43% | 19/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 5.11% | 60.19% | -72.29% | 12/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 18.44% | 7.9% | 41.19% | 25/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 13.06% | -8.54% | 76.49% | 24/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 7.4% | -14.05% | 131.97% | 33/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 3.19% | -10.89% | -81.33% | 30/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 17.09% | 11.77% | 19.68% | 27/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 14.28% | 23.42% | 65.85% | 15/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 8.61% | 17.62% | 140.5% | 21/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.58% | 22.18% | -76.59% | 28/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 15.29% | 19.36% | 32.15% | 30/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 11.57% | 20.77% | 58.06% | 17/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 7.32% | 17.68% | 149.83% | 21/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.93% | -40.57% | -77.13% | 32/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 12.81% | -49.11% | 33.72% | 34/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 9.58% | 2% | 54.02% | 34/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 6.22% | -50.28% | 26.17% | 35/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 4.93% | 2% | -80.41% | 7/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 25.17% | 12.32% | 101.2% | 9/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 12.51% | 20.99% | -44.18% | 4/160 | 3.53% | 南新制药 | 81.7% | 行业排名> |
| 2015-12-31 | 22.41% | -4.11% | -4.11% | 20/160 | 11.35% | 德展健康 | 29.5% | 行业排名> |